CBD

cbdMD, Inc. will host an earnings call on February 17, 2026, to discuss Q1 2026 financial results and operational progress. The discussion will cover performance across their diverse product lines, including THC-free CBD, Delta-9, pet products, functional mushrooms, and their new THC-infused seltzer, Herbal Oasis. Investors will seek insights into their market strategy and competitive positioning within the evolving cannabinoid industry. A webcast and dial-in option are available.

Xebra Brands terminated its acquisition of BSK Holdings Inc. but maintains a strong manufacturing and distribution partnership for its ELEMENTS™ CBD line in the U.S. The company is addressing delays in audited financial statements due to management transitions and liquidity issues, securing a C$110,000 loan to support operations and the audit. Xebra is a Canadian cannabis firm focused on wellness products, notably in Mexico and expanding across North America.